WHO CAM Strategy Advocates Creation Of National Policies, Increased R&D
This article was originally published in The Tan Sheet
Executive Summary
The World Health Organization has developed a strategy to double the number of member states with a national policy and legal framework for dealing with complementary and alternative medicine by 2005
You may also be interested in...
Kava Labeling Revisions Adopted By Trade Groups; FDA Issues Advisory
Various dietary supplement trade associations adopted revised kava labeling requirements for their member companies following the release of an 1FDA consumer advisory on the botanical
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands